BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 15765199)

  • 1. Epstein Barr-virus (EBV) associated T-cell clonopathy mimicking lymphomatous meningitis.
    Hermann DM; Fehr J; Bassetti CL
    J Neurol; 2005 Jun; 252(6):736-7. PubMed ID: 15765199
    [No Abstract]   [Full Text] [Related]  

  • 2. Epstein-Barr virus and multiple sclerosis: cellular immune response and cross-reactivity.
    Lindsey JW; Hatfield LM
    J Neuroimmunol; 2010 Dec; 229(1-2):238-42. PubMed ID: 20826010
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epstein-Barr virus-positive mucocutaneous ulcer.
    Chen BJ; Fang CL; Chuang SS
    Kaohsiung J Med Sci; 2017 Jan; 33(1):50-51. PubMed ID: 28088274
    [No Abstract]   [Full Text] [Related]  

  • 4. Concomitant Epstein-Barr virus (EBV)-positive B-cell and EBV-negative T-cell posttransplant lymphoproliferative disorders after renal allografting: pathogenetic implications.
    Au WY; Lam MF; Pang A; Leung RY; Kwong YL
    Transplantation; 2011 Dec; 92(12):e67-8. PubMed ID: 22158471
    [No Abstract]   [Full Text] [Related]  

  • 5. Seronegative Epstein-Barr virus myeloradiculitis in an immunocompetent 72-year-old woman.
    Mühlau M; Bülow S; Stimmer H; Schätzl H; Berthele A
    Neurology; 2005 Oct; 65(8):1329-30. PubMed ID: 16247075
    [No Abstract]   [Full Text] [Related]  

  • 6. T cell repertoire and Epstein-Barr virus-specific T cell response in chronic active Epstein-Barr virus infection: a case study.
    Gallot G; Hamidou MA; Clémenceau B; Gaschet J; Tiberghien P; Ferrand C; Vivien R; Barbarot S; Coste-Burel M; Moreau A; Vié H
    Clin Immunol; 2006 Apr; 119(1):79-86. PubMed ID: 16386957
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hydroa Vacciniforme-like Skin Lesions in Epstein-Barr-Virus-associated T-cell Lymphoproliferation with Subsequent Development of Aggressive NK/T-cell Lymphoma.
    Toksoy A; Strifler S; Benoit S; Grigoleit GU; Knop S; Mielke S; Buder-Bakhaya K; Roth S; Goebeler M; Rosenwald A; Geissinger E; Wobser M
    Acta Derm Venereol; 2017 Mar; 97(3):379-380. PubMed ID: 27826612
    [No Abstract]   [Full Text] [Related]  

  • 8. Persistence of the Epstein-Barr virus and the origins of associated lymphomas.
    Thorley-Lawson DA; Gross A
    N Engl J Med; 2004 Mar; 350(13):1328-37. PubMed ID: 15044644
    [No Abstract]   [Full Text] [Related]  

  • 9. Subacute sensory neuropathy associated with Epstein-Barr virus.
    Rubin DI; Daube JR
    Muscle Nerve; 1999 Nov; 22(11):1607-10. PubMed ID: 10514244
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epstein-Barr virus-positive T/NK-cell lymphoproliferative disorders.
    Cai Q; Chen K; Young KH
    Exp Mol Med; 2015 Jan; 47(1):e133. PubMed ID: 25613730
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epstein-Barr virus infections of the nervous system.
    Tselis AC
    Handb Clin Neurol; 2014; 123():285-305. PubMed ID: 25015491
    [No Abstract]   [Full Text] [Related]  

  • 12. New approaches to treating B-cell cancers induced by Epstein-Barr virus.
    Dharnidharka VR; Mohanakumar T
    N Engl J Med; 2015 Feb; 372(6):569-71. PubMed ID: 25651254
    [No Abstract]   [Full Text] [Related]  

  • 13. Epstein Barr virus specific T-cells generated from unstable human atherosclerotic lesions: Implications for plaque inflammation.
    de Boer OJ; Teeling P; Idu MM; Becker AE; van der Wal AC
    Atherosclerosis; 2006 Feb; 184(2):322-9. PubMed ID: 15941569
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Encephalitis lethargica due to Epstein-Barr virus infection.
    Alarcón F; Dueñas G; Lees A
    Mov Disord; 2011 Sep; 26(11):2132-4. PubMed ID: 21611982
    [No Abstract]   [Full Text] [Related]  

  • 15. The human T cell immune response to Epstein-Barr virus.
    Landais E; Saulquin X; Houssaint E
    Int J Dev Biol; 2005; 49(2-3):285-92. PubMed ID: 15906243
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epidermal cell necrosis with direct epidermal infiltration of Epstein-Barr virus (EBV)-encoded small nuclear RNA-positive T lymphocytes in a patient with EBV-associated haemophagocytic syndrome.
    Kawachi Y; Itoh M; Fujisawa Y; Furuta J; Nakamura Y; Banno T; Takahashi T; Otsuka F
    Br J Dermatol; 2007 Nov; 157(5):1053-6. PubMed ID: 17725675
    [No Abstract]   [Full Text] [Related]  

  • 17. Clonal origin of Epstein-Barr virus (EBV)-infected T/NK-cell subpopulations in EBV-positive T/NK-cell lymphoproliferative disorders of childhood.
    Ohga S; Ishimura M; Yoshimoto G; Miyamoto T; Takada H; Tanaka T; Ohshima K; Ogawa Y; Imadome K; Abe Y; Akashi K; Hara T
    J Clin Virol; 2011 May; 51(1):31-7. PubMed ID: 21377409
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intracranial Epstein-Barr virus infection appearing as an unusual case of meningitis in an immunocompetent woman: a case report.
    Wang Y; Dong Q; Chen YD; Hu WL; Zhao L
    J Int Med Res; 2020 Feb; 48(2):300060520903215. PubMed ID: 32046554
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epstein-Barr virus-targeted immunotherapy for nasopharyngeal carcinoma.
    Masmoudi A; Toumi N; Khanfir A; Kallel-Slimi L; Daoud J; Karray H; Frikha M
    Cancer Treat Rev; 2007 Oct; 33(6):499-505. PubMed ID: 17544585
    [TBL] [Abstract][Full Text] [Related]  

  • 20. T/NK cell type chronic active Epstein-Barr virus disease in adults: an underlying condition for Epstein-Barr virus-associated T/NK-cell lymphoma.
    Isobe Y; Aritaka N; Setoguchi Y; Ito Y; Kimura H; Hamano Y; Sugimoto K; Komatsu N
    J Clin Pathol; 2012 Mar; 65(3):278-82. PubMed ID: 22247563
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.